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Introduction
In cardiac surgery involving cardio-pulmonary bypass, AKI
is a relatively common diagnosis. In recent years a number
of new biomarkers have been undergoing validation in this
clinical setting. It is thought that earlier detection of AKI
will offer opportunities for new therapeutic interventions
Objectives
Analysis of a database was performed to define baseline
patient and biomarker characteristics in patients develop-
ing AKI in a population of cardiac surgery patients under-
going cardiopulmonary bypass as part of the procedure.
Methods
In total, 259 patients were enrolled, after the exclusion of
patients with severe pre-existing renal insufficiency
(defined as a eGFR< 15 ml/min). As part of a broader
study, urine and blood samples were obtained immediately
before initiation of cardio-pulmonary bypass. Patients were
subsequently retrospectively divided into 2 groups, AKI
(n=84) and non-AKI (n=175). This subdivision was based
on based on the AKIN criteria i.e. increase in s-Creat ≥ 0.3
mg/dl or ≥ 50% compared to baseline within 48 h or
reduction in urine output < 0.5 ml/kg/h for more than
6 h. Statistical analysis of all characteristics before arrival
on the ICU was performed.
Results
AKI patients (32% of total) were older (70 yrs (SD = 9)
vs 67 (11), p =0.043) with higher BMI´s (27.7 (4.8)
vs.26.7 (4.3), p = 0.036). As to be expected baseline
eGFR (CKD-EPI, in ml/min) was lower in the AKI-
group (69.49 (20.30) vs. 76.45 (15.01), p = 0.024). Both
baseline urinary-NGAL (µg/l)(1211 (2172) vs.749 (946),
p = 0.020) and serum-cystatin C (in mg/L)(0.98 (0.39) vs
0.86 (0.36), p = 0.0175) were statistically higher in the
AKI group and CPB time (in minutes) was significantly
longer: 163 (63) vs 121 (51), p < 0.0001.
Conclusions
Urinary-NGAL and serum-Cystatin most likely reflect
pre-existing kidney dysfunction (like eGFR). Length of
cardiopulmonary bypass time is a significant factor for
development of AKI, which is amenable to improvement.
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